Table 1. HCV detection in three series of subjects.

Subjects	Number of subjects	HCV antibodies (%)	HCV –RNA plasma (%)	HCV –RNA PBMCs (%)a
All series
All subjects	276	0 (0)	0 (0)	9 (3.3%)
Men (age range: 36–65 years)	111	0 (0)	0 (0)	3 (2.7%)
Women (age range: 39–76 years)	165	0 (0)	0 (0)	6 (3.6%)
EPIC Italy-cohort series
All subjects	176	0 (0)	0 (0)	7 (4.0%)
Men (age range: 36–65 years)	71	0 (0)	0 (0)	3 (4.2%)
Women (age range: 39–76 years)	105	0 (0)	0 (0)	4 (3.8%)
Turin Case-Control Bladder Cancer series(controls)
Men (age range: 42–66 years)	40	0 (0)	0 (0)	0 (0%)
Cervical Cancer Screening series
Women (age range: 46–61 years)	60	0 (0)	0 (0)	2 (3.3%)

^aPBMCs, peripheral blood mononuclear cells.